Bioinformatics Services Market

Bioinformatics Services Market Overview

The global bioinformatics services market, valued at USD 3.49 billion in 2024, is projected to reach USD 4.09 billion in 2025 and USD 14.94 billion by 2035, representing a CAGR of 13.8% during the forecast period.

Bioinformatics services refer to the scientific field that utilizes computer technology and software for the analysis of biological data generated from a wide range of sources. This service industry is witnessing an upward trajectory driven by the increasing usage of bioinformatics in the pharmaceutical industry.

Bioinformatics tools and technologies help to interpret complex data collected from sequencing technologies to identify drug targets, side effects, genomics and underlying causes of diseases to develop tailored drugs. Conventionally, the identification of drug targets and clinical studies done manually which is time consuming, error prone and may provide false results, ultimately delay the approval process. By leveraging bioinformatics services, scientists can streamline the entire workflow and reduce manual errors, which significantly improve approval chances.

In addition, the growing research on genomics and metabolomics to develop personalised drugs based on an individual's genome profile to meet unmet requirements has further accelerated the adoption of bioinformatics services.

Considering the ongoing demand, various industrial players are accelerating the development of innovative bioinformatics services and platforms. For instance, in September 2024, Almaden Genomics launched the latest data management and informatics services to support synthetic biology, computational biology and bioinformatics solutions. The expansion has been done to advance life sciences research by offering scalable solutions that help in managing and analysing data across multiple domains, such as diagnostics, drug discovery and development.

Similarly, companies, such as Agilent Technologies, Illumina and Thermo Fisher Scientific are undertaking strategic initiatives to develop advanced bioinformatic services and platforms to support research on novel drugs. Driven by the ongoing initiatives, we believe that the bioinformatics services market will continue to expand at a steady rate during the forecast period.

Bioinformatics Services Market Segmentation Insights

The market report provides comprehensive information on bioinformatics service providers who are currently active across various segments of the industry as mentioned in the table below.

Bioinformatics Services Market: Report Attributes / Market Segmentation

Available

Key Report Attributes	Details
Historical Trend	Since 2020
Forecast Period	Till 2035
Market Size 2025	USD 4.09 Billion
Market Size 2035	USD 14.94 Billion
CAGR (till 2035)	13.8%
Type of Product / Service	Sequencing Services Data Analysis Services Gene Expression Drug Discovery Services Data Base Management Other Products
Application Area	Genomics Metabolomics Proteomics Drug Design Transcriptomics Other Applications
End User	Hospitals & Clinics Pharmaceutical & Biotechnology Companies Academic Institutes & Research Centers Other End Users
Geographical Regions	North America (US, Canada, Mexico) Europe (France, Germany, Italy, Spain, UK and Rest of Europe) Asia-Pacific (China, India, Japan, South Korea, and Rest of Asia-Pacific) Middle East and North Africa (Egypt, Saudi Arabia and United Arab Emirates) Latin America (Argentina and Brazil)
Key Companies Profiled	Agilent Technologies Accelerys BGI Group CD Genomics Celera Creative Biolabs DNAnexus DNASTAR Dotmatics Fios Genomics Illumina IBM Life Sciences Labvantage (Biomax) Life Technologies PerkinElmer QIAGEN Thermo Fisher Scientific (A complete list of companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization
Excel Data Packs (Complimentary)	Available

One of the key objectives of the bioinformatics services market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.

The global market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of product / service (sequencing services, data analysis services, gene expression, drug discovery services, data base management and other products), application area (genomics, metabolomics, proteomics, drug design, transcriptomics, and other applications) by end user (hospitals & clinics, pharmaceutical & biotechnology companies, academic institutes & research centers and other end users), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.

In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three bioinformatics services market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.

All actual figures have been sourced and analysed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.

Bioinformatics Services Market Share Insights

Market Share by Type of Product / Service

Based on the type of product / service, the global market is segmented into sequencing services, data analysis services, gene expression, drug discovery services, data base management and other product types. According to our bioinformatics services market analysis, the sequencing services segment accounts for the highest share (32%) of the market. This can be attributed to the expanding usage of next generation sequencing technologies for genomic research and development of personalized drugs.

The data generated through next generation sequencing is widely interpreted through bioinformatics tools and technologies, which is expected to be a key reason for the highest share of this segment. Driven by the increasing adoption of next generation sequencing technologies, this segment will continue to maintain its dominance in the market and is expected to grow at a higher CAGR during the forecast period.

Market Share by Application Area

This segment highlights the distribution of the global market across different application areas, such as genomics, metabolomics, proteomics, drug design, transcriptomics, and other applications. Currently, genomics accounts for the largest share (36%) of the market for bioinformatics services. This is likely the result of increasing genomic research to understand the underlying cause of diseases and identification of biomarkers for diagnosis. Moreover, genomics is currently widely adopted to develop tailored targeted therapies, which is further contributed to the highest share of this segment.

However, in the long run, the metabolomics segment is likely to register a higher CAGR during the forecast period. This can be attributed to the fact that metabolomics helps to understand the underlying disease mechanism and develop personalized drugs.

In addition to metabolomics, the drug design segment is also likely to gain traction at a substantial rate driven by the growing adoption of sequencing services for drug target identification and development which further underscored the demand for bioinformatics services.

Market Share by End User

Based on the end user, the global market is distributed into hospitals & clinics, pharmaceutical & biotechnology companies, academic institutes & research centers, and other end users. According to our projection, presently pharmaceutical & biotechnology companies hold the largest bioinformatics services market share (45%). This can be attributed to the increasing genomic research, disease studies and drug discovery & development for wide range of disease indications. Additionally, the increasing support from government organizations to use advanced technologies for drug studies has contributed to the highest share of this segment.

However, in the long run, academic institutes & research centers segment is likely to grow at a higher CAGR during the forecast period. This is likely to be the result of increasing research on genomics and metabolomics for understanding disease mechanism.

Market Share by Geographical Regions

The global market is distributed across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. According to market analysis, currently North America accounts for the largest bioinformatics services market share (42%). This can be attributed to the increasing research activities by established pharmaceutical companies and research organizations on tailored drugs that necessitated the demand for bioinformatics services for data exploration.

However, in Asia-Pacific, the market for bioinformatics services is expected to grow at a higher CAGR during the forecast period. Bioinformatics services play a significant role in interpreting vast amounts of data generated during cancer genomic studies collected through next generation sequencing and other analysis technologies. Thus, increasing research on cancer genomics to identify cancer biomarkers and tumor-specific genetic mutations in this region is likely to be a key reason for unprecedented growth.

Bioinformatics Services Market Dynamic Insights

The “Bioinformatics Services Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for bioinformatics service providers. Key takeaways of this industry report are briefly discussed below.

Bioinformatics Services Market Competitive Landscape

Currently, the market landscape of bioinformatics service providers is witnessing a wide array of well-established and new entrants. These industrial players are focusing on expanding technological innovations and launching new services and platforms to support drug research and disease studies.

In order to leverage competitive edge, several industrial players are entering into collaboration and partnership agreements. For instance, in January 2025, Basepair announced a distribution agreement with Sciencewerke to enhance access to Basepair’s federated and user-friendly bioinformatics platform across Southeast Asia. The collaboration aims to address the growing requirement for accessible bioinformatics tools for genomic research in Southeast Asian countries.

Similarly, several small, mid-sized and large industrial players are undertaking strategic initiatives to expand bioinformatics tools and services, which is likely to maintain a competitive edge in the market.

Market Drivers: Bioinformatics Workflow Optimization for Transcriptomics Analysis and Increasing Research on Personalized Drugs and Genomic Research

The rapid advancements in high-throughput sequencing technologies and platforms for genome analysis has accelerated the demand for bioinformatics tools and services for data interpretation. Additionally, the increasing preferences for targeted / personalized therapies has further increased the adoption of bioinformatics tools for target drug identification and drug designing. Furthermore, the increasing support from government and private sectors in bioinformatics research has further fuelled the market growth during the projected period.

Market Challenges: Lack of Skilled Personnel, Data Complexity and Management

Despite heightened demand, there are several challenges that need to be addressed. Some of the potential challenges include data complexity and management, lack of skilled personnel and standardization. It is important to highlight here that bioinformatics tools and technologies deal with huge amounts of complex datasets that may require highly sophisticated tools for interpretation.

Additionally, the field of bioinformatics lacks standardised protocols which create challenges in sharing complex data across diverse platforms. Moreover, shortage of skilled personnel for technology operation may create significant barriers in market growth.

Bioinformatics Services Market Trends: Integration of Artificial Intelligence, Big Data Analytics, Expanding Applications, and Increasing R&D Activities

The market for bioinformatics services is continually gaining traction driven by the increasing integration of artificial intelligence and big data analytics for data interpretation in real time. It is worth noting that artificial intelligence and cloud computing are increasingly gaining attention in bioinformatics as it enables faster and accurate data interpretation.

Furthermore, the expanding applications of bioinformatics tools beyond pharmaceutical and academic research, such as agriculture and veterinary field for genome studies are offering enormous opportunities for driving innovation in this field. Additionally, increasing R&D activities on advanced drugs and biomarkers are the key trends shaping the industry growth during the forecast period.

Bioinformatics Services Market Size Analysis

Currently, the global bioinformatics services market is expected to be valued at USD 4.09 billion in 2025 and is poised to reach USD 14.94 billion by 2035, representing a CAGR of 13.8% during the forecast period. This lucrative growth is primarily driven by the expanding adoption of bioinformatics services for data analysis and interpretation which is collected during drug discovery and clinical studies.

In order to make bioinformatics services / platforms accessible across the globe, several industrial players are forging strategic partnerships and collaborations. For instance, in September 2024, Generate:Biomedicines announced a multi-target collaboration with Novartis that worth around USD 1 billion to leverage Generate’s proprietary generative AI platform “The Generate Platform” for the development of protein therapeutics. This collaboration will combine “The Generate Platform” with Novartis capabilities and expertise in biologics development.

Leading Companies in Bioinformatics Services Market

Examples of key players engaged in this domain (which have also been captured in this report) include Agilent Technologies, Accelerys, BGI Group, CD Genomics, Celera, Creative Biolabs, DNAnexus, DNASTAR, Dotmatics, Fios Genomics, Illumina, IBM Life Sciences, Labvantage (Biomax), Life Technologies, PerkinElmer, QIAGEN and Thermo Fisher Scientific. This market report includes an easily searchable excel database of all the companies focusing on the development of bioinformatics tools and technologies.

Bioinformatics Services Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various bioinformatic service providers engaged in this domain across different segments. Amongst other elements, the market report includes:

• A preface providing an introduction to the full report, Bioinformatics Services Market, 2020-2024 (Historical Trends), and Future Forecast till 2035 (Forecasted Estimates).
• An outline of the systematic research methodology adopted to conduct the study on the market for bioinformatics services, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
• An overview of economic factors that impact the overall bioinformatics services industry, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
• An executive summary of the insights captured during our research. It offers a high-level view of the current state of the global market for bioinformatics services and its evolution in the mid-and long-term.
• A detailed assessment of the bioinformatics service providers landscape is based on several relevant parameters, including years of experience, company size, headquarters location, and ownership structure.
• Elaborated profiles of prominent players engaged in offering bioinformatics services, featuring information on their year of establishment, location of headquarters, company size, company mission, company footprint, management team, contact details, financial information, operating business segments, bioinformatics services portfolio, recent developments, and an informed future outlook.
• A discussion on affiliated trends, key drivers, and challenges under a SWOT framework, which is likely to impact the industry's evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall bioinformatics services industry.
• A market impact analysis features a discussion on the factors that can impact the growth of the bioinformatics services market.
• A detailed estimate of the current market size and the future growth potential of the market for bioinformatics services over the next decade. based on multiple parameters, we have provided an informed estimate of the market's evolution during the forecast period till 2035. The report also features the likely distribution of the current and forecasted opportunities within the bioinformatics services industry. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
• Detailed projections of the current and future bioinformatics services market across various types of product, including sequencing services, data analysis services, gene expression, drug discovery services, data base management and other products.
• Detailed projections of the current and future market for bioinformatics services across various application area, including Genomics, Metabolomics, Proteomics, Transcriptomics, and Other Applications.
• Detailed projections of the current and future opportunities for bioinformatics service providers across various types of end users, including Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers and Other End Users.
• Detailed projections of the current and future market for bioinformatics services across various key geographical regions, such as North America (US, Canada and Mexico), Europe (France, Germany, Italy, Spain, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, Russia, Thailand, Malaysia, Indonesia and Rest of the Asia-Pacific), Middle East and North Africa (Egypt, Saudi Arabia and UAE), and Latin America (Argentina and Brazil).

Recent Developments in Bioinformatics Services Market

Several recent developments have taken place in the field of bioinformatics services. We have outlined some of these recent initiatives below.

• In January 2025, Illumina and NVIDIA entered a partnership to apply AI technology and genomics for analysis and interpretation of multi-omics data in clinical research, drug discovery and human health. Under this partnership, Illumina will provide ins DRAGEN analysis software on NVIDIA’s accelerated computing platform and also make NVIDIA’s BioNeMO tools available on the Illumina Connected Analytics (ICA) platform.
• In October 2024, IDIBAPS created an advanced research computing platform to meet with requirement of researchers for research studies. The aim of launch new computing platform is to manage storage, data transfer, and analyses the research training in the field of bioinformatics.
• In October 2024, Bioinformatics firm MiLaboratories announced about successful closing of $10 million series A funding round and the launch of its Platforma.bio Software Development Kit (SDK). The company will utilize these funds for the strategic expansion of its bioinformatics operations with a focus on the US market.